Drug Use Among American Workers Declined 74% Over Past 25 Years, Finds Unprecedented Analysis of More Than 125 Million Workplace Urine Drug Tests
For a version of this press release with comprehensive data tables and graphics, visit www.QuestDiagnostics.com/DTI
The special 25th anniversary Drug Testing Index (DTI) coincides with the passage of the Drug-Free Workplace Act in 1988, which was a catalyst for greater awareness of the problem of workplace drug use and the implementation of workplace drug education and monitoring programs, including drug testing, by federal agencies and private employers in
"Today's Quest Diagnostics Drug Testing Index provides the best evidence to date that the Drug-Free Workplace Act and the public and private initiatives it helped to spur have led to steep declines in drug use among much of the American workforce," said
The DTI analysis examined more than 125 million urine drug tests performed by
Key findings from the analysis:
- The positivity rate for the combined U.S. workforce declined 74%, from 13.6% in 1988 to 3.5% in 2012.
- The positivity rate for the federally-mandated safety sensitive workforce declined by 38%, from 2.6% in 1992 to 1.6% in 2012.
- The positivity rate for the U.S. general workforce declined by 60%, from 10.3% in 1992 to 4.1% in 2012.
Despite the declines in overall drug use, the DTI analysis also found that the positivity rate for certain segments of drugs has increased.
- Positivity rates for amphetamines, including amphetamine and methamphetamine, has nearly tripled (196% higher) in the combined U.S. workforce and, in 2012, were at the highest level since 1997. The positivity rate for amphetamine itself, including prescription medications such as Adderall®, has more than doubled in the last 10 years.
- Positivity rates for prescription opiates, which include the drugs hydrocodone, hydromorphone, oxycodone and oxymorphone, have also increased steadily over the last decade – more than doubling for hydrocodone and hydromorphone and up 71% for oxycodone – reflective of national prescribing trends.
These data are consistent with other studies, including a 2012 Quest Diagnostics Health Trends analysis of more than 75,000 test results from patients tested for compliance through the company's prescription drug monitoring services. This report found that the majority of Americans misused their prescription medications, including opioids and amphetamine medications.
The DTI report also found that changing positivity rates often mirrored larger developments in drug use in the U.S. For instance, a decline in drug positives for methamphetamine observed in 2005 roughly coincided with federal and state efforts to crackdown on so-called "meth labs" and put over-the-counter medicines – such as ephedrine and pseudoephedrine – behind the pharmacy counter.
"While this 'Silver Anniversary' Drug Testing Index underscores the nation's progress in reducing the prevalence of drug use in our country's work environments, there is a danger in becoming complacent in response to this good news," said Dr.
"Some industries such as the restaurant industry have adopted an attitude that drug use in their industry is something they cannot control. The fact remains that drugs in the workforce contribute to industrial and other accidents, not to mention employer costs and liability," said
The Drug-Free Workplace Act of 1988 requires federal contractors and all federal grantees to agree to provide drug-free workplaces as a precondition of receiving a contract or grant from a federal agency. Although the Act did not mandate mandatory drug testing, federal agencies subsequently promulgated drug testing regulations affecting "safety-sensitive" employees and other federal employees. Many private employers also created policies consistent with the federal requirements in order to minimize the hazards of drug use in the workplace.
"The Drug Testing Index is more than an established barometer of workplace drug use trends. Quest's DTI demonstrates the power of diagnostic insights to reveal opportunities to create a healthier and safer world," said
The strengths of the DTI analysis include its unprecedented sample size, the longitudinal nature of the monitoring, a testing population that is generally reflective of the U.S. workforce, and the quality of the company's drug testing services to confirm positive results. Limitations include the selection of the testing population, which is reflective only of results from employers that perform drug testing, and a lack of exact cross-specimen comparisons due to variations in substances for which employers test. DTI reports involve analysis of de-identified results from urine, oral fluid and hair drug tests.
About the Quest Diagnostics Drug Testing Index
The Quest Diagnostics Drug Testing Index is published as a public service for government, media and industry and is considered a benchmark for national trends. DTI reports examines positivity rates for workplace drugs tested by the company on behalf of employers among three major testing populations: federally mandated safety-sensitive workers; the general workforce; and the combined U.S. workforce. For more information, visit www.QuestDiagnostics.com/DTI or www.EmployerSolutions.com.
For more information on the company's prescription drug monitoring services for clinicians, visit www.QuestDiagnostics.com/prescriptiondrugmonitoring.
Quest Diagnostics Contacts:
Jenny Dudikoff, KP, 916-224-9429
Image with caption: "Drug Use Among American Workers Declined 74% Over Past 25 Years Finds Analysis by Quest Diagnostics." Image available at: http://photos.prnewswire.com/prnh/20131118/NY18408-INFO-a
Image with caption: "Dr.
Image with caption: "